Publications
in officia veniam est ad esse laboris ea anim sit officia minim irure consequat ipsum voluptate labore anim in mollit mollit officia aliqua aliqua elit excepteur non aliqua sint in proident eu culpa nostrud ea veniam ad labore anim consequat velit
Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 1993;82(4):1300-1307.
Siegmund D, Ehrenschwender M, Wajant H. TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling. Cell Death Dis. 2018 Sep 11;9(9):921. doi: 10.1038/s41419-018-0973-3.
Bittner, S. et al. (2022) ‘Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy’, Proceedings of the National Academy of Sciences, 119(40), p. e2208436119. Available at: https://doi.org/10.1073/pnas.2208436119.
Bencurova, E. et al. (2022) ‘Nanocellulose Composites as Smart Devices With Chassis, Light-Directed DNA Storage, Engineered Electronic Properties, and Chip Integration’, Frontiers in Bioengineering and Biotechnology, 10, p. 869111. Available at: https://doi.org/10.3389/fbioe.2022.869111.
Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, Retzlaff J, Dörrie J, Schaft N, Wiesinger M, März J, Schuler-Thurner B, Knorr H, Gupta S, Singh KP, Schuler G, Heppt MV, Koch EAT, van Kleef ND, Freen-van Heeren JJ, Turksma AW, Wolkenhauer O, HohbergerB, Berking C, Bruns H, Vera J. Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy. J Immunother Cancer. 2024 May 9;12(5):e008104.
Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, Altmeyer S, Bittenbring JT, Augsberger C, Ilieva-Babinsky K, Haskamp S, Beier F, Lischer C, Vera J, Lührmann A, Bertz S, Völkl S, Jacobs B, Steidl S, Mackensen A, Bruns H. Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated anti-tumor efficacy of tafasitamab. Haematologica. 2024 Jun 27. doi: 10.3324/haematol.2023.284795.
